COL1A2 and osteogenesis imperfecta: In this study, our objective is to broaden the understanding of the genetic and clinical characteristics of OI by investigating rare PVs not only within the well-established COL1A1 and COL1A2, which are responsible for more than 85%–90% of all cases but also in other genes involved in OI.